| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.19 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.2 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |